German financial regulator expands probe into Gerresheimer's financial statements
25/02/2026 18:26
Feb 25 - Germany's financial regulator BaFin has expanded its audit of medical equipment maker Gerresheimer's GXIG.DE 2024 financial statements and initiated a fresh audit into the company's 2025 half-yearly financial report, the company said in a statement on Wednesday. (Reporting by Kanjyik Ghosh in Barcelona; Editing by Toby Chopra) ((kanjyik.ghosh@thomsonreuters.com))
Recent news on Gerresheimer AG
See all newsGermany's Gerresheimer prelim Q3 revenue rises on strong demand for drug delivery devices
Brief: Gerresheimer Reports Q3 Revenue Of EUR 605 Mln
Brief: Gerresheimer Completes Sale Of Centor
Brief: Gerresheimer Targets Leverage At Or Below 3x Net Debt To Ebitda
Gerresheimer gains as Q2 shows quarter-on-quarter recovery